More about
Sacituzumab Govitecan
News
September 19, 2020
4 min read
Save
Sacituzumab govitecan improves survival in pretreated triple-negative breast cancer
Sacituzumab govitecan significantly improved PFS and OS compared with single-agent chemotherapy.
News
April 23, 2020
1 min read
Save
FDA approves Trodelvy for metastatic triple-negative breast cancer
The FDA granted accelerated approval to sacituzumab govitecan-hziy for treatment of certain adults with metastatic triple-negative breast cancer.
News
April 09, 2020
1 min read
Save
FDA grants fast track designation to sacituzumab govitecan for urothelial cancer subset
The FDA granted fast track designation to sacituzumab govitecan for treatment of certain adults with locally advanced or metastatic urothelial cancer.
News
August 21, 2024
3 min watch
Save
VIDEO: Recent approvals in breast cancer
Healio spoke with Roberto A. Leon-Ferre, MD, about recent approvals in breast cancer.